These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

64 related articles for article (PubMed ID: 9266775)

  • 1. Serotonin-1A antagonists attenuate the effects of nicotine withdrawal on the auditory startle response.
    Rasmussen K; Kallman MJ; Helton DR
    Synapse; 1997 Oct; 27(2):145-52. PubMed ID: 9266775
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Enhancement of serotonin-1A receptor dependent responses following withdrawal of haloperidol in rats.
    Haleem DJ; Khan NH
    Prog Neuropsychopharmacol Biol Psychiatry; 2003 Jun; 27(4):645-51. PubMed ID: 12787852
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The counteraction of opioid-induced ventilatory depression by the serotonin 1A-agonist 8-OH-DPAT does not antagonize antinociception in rats in situ and in vivo.
    Guenther U; Manzke T; Wrigge H; Dutschmann M; Zinserling J; Putensen C; Hoeft A
    Anesth Analg; 2009 Apr; 108(4):1169-76. PubMed ID: 19299781
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The novel 5-Hydroxytryptamine(1A) antagonist LY426965: effects on nicotine withdrawal and interactions with fluoxetine.
    Rasmussen K; Calligaro DO; Czachura JF; Dreshfield-Ahmad LJ; Evans DC; Hemrick-Luecke SK; Kallman MJ; Kendrick WT; Leander JD; Nelson DL; Overshiner CD; Wainscott DB; Wolff MC; Wong DT; Branchek TA; Zgombick JM; Xu YC
    J Pharmacol Exp Ther; 2000 Aug; 294(2):688-700. PubMed ID: 10900249
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The opposite effect of a low and a high dose of serotonin-1A agonist on behavior induced by MK-801.
    Bubeníková-Valesová V; Votava M; Pálenícek T; Horácek J
    Neuropharmacology; 2007 Mar; 52(4):1071-8. PubMed ID: 17196227
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reduction of 5-hydroxytryptamine (5-HT)(1A)-mediated temperature and neuroendocrine responses and 5-HT(1A) binding sites in 5-HT transporter knockout mice.
    Li Q; Wichems C; Heils A; Van De Kar LD; Lesch KP; Murphy DL
    J Pharmacol Exp Ther; 1999 Dec; 291(3):999-1007. PubMed ID: 10565817
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 5-Hydroxytryptamine(1A) receptor activation enhances norepinephrine release from nerves in the rabbit saphenous vein.
    Cohen ML; Schenck KW; Hemrick-Luecke SH
    J Pharmacol Exp Ther; 1999 Sep; 290(3):1195-201. PubMed ID: 10454495
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nicotine withdrawal leads to increased firing rates of midbrain dopamine neurons.
    Rasmussen K; Czachura JF
    Neuroreport; 1995 Dec; 7(1):329-32. PubMed ID: 8742482
    [TBL] [Abstract][Full Text] [Related]  

  • 9. WAY-100635 antagonist-induced plasticity of 5-HT receptors: regulatory differences between a stable cell line and an in vivo native system.
    Khawaja XZ; Smith DL; Nawoschik SP; Zhang J; Dunlop J; Dilks DW; Olsen M; Schechter LE
    J Neurochem; 2006 Jul; 98(1):134-45. PubMed ID: 16805803
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ambient temperature influences core body temperature response in rat lines bred for differences in sensitivity to 8-hydroxy-dipropylaminotetralin.
    Nicholas AC; Seiden LS
    J Pharmacol Exp Ther; 2003 Apr; 305(1):368-74. PubMed ID: 12649391
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Peripheral 5-HT1A receptors are not essential for increased ventilation evoked by systemic 8-OH-DPAT challenge in anaesthetized rats.
    Szereda-Przestaszewska M; Kaczyńska K
    Exp Physiol; 2007 Sep; 92(5):953-61. PubMed ID: 17526557
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of peripheral 5-HT1A receptors in detrusor over activity associated with partial bladder outlet obstruction in female rats.
    Mittra S; Malhotra S; Naruganahalli KS; Chugh A
    Eur J Pharmacol; 2007 Apr; 561(1-3):189-93. PubMed ID: 17320854
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Unilateral lesion of the nigrostriatal pathway induces an increase of neuronal firing of the midbrain raphe nuclei 5-HT neurons and a decrease of their response to 5-HT(1A) receptor stimulation in the rat.
    Wang S; Zhang QJ; Liu J; Wu ZH; Wang T; Gui ZH; Chen L; Wang Y
    Neuroscience; 2009 Mar; 159(2):850-61. PubMed ID: 19174182
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The CCK-B antagonist LY288513 blocks the effects of nicotine withdrawal on auditory startle.
    Rasmussen K; Czachura JF; Kallman MJ; Helton DR
    Neuroreport; 1996 Apr; 7(5):1050-2. PubMed ID: 8804049
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Stimulation of 5-HT(1A) receptors in the dorsal raphe ameliorates the impairment of spatial learning caused by intrahippocampal 7-chloro-kynurenic acid in naive and pretrained rats.
    Carli M; Balducci C; Samanin R
    Psychopharmacology (Berl); 2001 Oct; 158(1):39-47. PubMed ID: 11685382
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of 5-HT(1A) receptor ligands on Fos-like immunoreactivity in rat brain: evidence for activation of noradrenergic transmission.
    Hajós-Korcsok E; Sharp T
    Synapse; 1999 Nov; 34(2):145-53. PubMed ID: 10502313
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of several 5-hydroxytryptamine(1A) receptor ligands on the micturition reflex in rats: comparison with WAY 100635.
    Testa R; Guarneri L; Poggesi E; Angelico P; Velasco C; Ibba M; Cilia A; Motta G; Riva C; Leonardi A
    J Pharmacol Exp Ther; 1999 Sep; 290(3):1258-69. PubMed ID: 10454502
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nicotine withdrawal leads to increased sensitivity of serotonergic neurons to the 5-HT1A agonist 8-OH-DPAT.
    Rasmussen K; Czachura JF
    Psychopharmacology (Berl); 1997 Oct; 133(4):343-6. PubMed ID: 9372532
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Coadministration of 5-hydroxytryptamine(1A) antagonist WAY-100635 prevents fluoxetine-induced desensitization of postsynaptic 5-hydroxytryptamine(1A) receptors in hypothalamus.
    Serres F; Muma NA; Raap DK; Garcia F; Battaglia G; Van de Kar LD
    J Pharmacol Exp Ther; 2000 Jul; 294(1):296-301. PubMed ID: 10871325
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Repeated adolescent 3,4-methylenedioxymethamphetamine (MDMA) exposure in rats attenuates the effects of a subsequent challenge with MDMA or a 5-hydroxytryptamine(1A) receptor agonist.
    Piper BJ; Vu HL; Safain MG; Oliver AJ; Meyer JS
    J Pharmacol Exp Ther; 2006 May; 317(2):838-49. PubMed ID: 16434566
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.